Global Uterine Fibroid Treatment Device Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Uterine Fibroid Treatment Device Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Surgical Techniques
- 1.2.3 Laparoscopic Techniques
- 1.2.4 Ablation Techniques
- 1.2.5 Embolization Technique
- 1.3 Market by Application
- 1.3.1 Global Uterine Fibroid Treatment Device Market Share by Application: 2020 VS 2026
- 1.3.2 Invasive Treatment
- 1.3.3 Minimally Invasive Treatment
- 1.3.4 Non-invasive Treatment
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Uterine Fibroid Treatment Device Market Perspective (2015-2026)
- 2.2 Global Uterine Fibroid Treatment Device Growth Trends by Regions
- 2.2.1 Uterine Fibroid Treatment Device Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Uterine Fibroid Treatment Device Historic Market Share by Regions (2015-2020)
- 2.2.3 Uterine Fibroid Treatment Device Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Uterine Fibroid Treatment Device Players by Market Size
- 3.1.1 Global Top Uterine Fibroid Treatment Device Players by Revenue (2015-2020)
- 3.1.2 Global Uterine Fibroid Treatment Device Revenue Market Share by Players (2015-2020)
- 3.2 Global Uterine Fibroid Treatment Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Uterine Fibroid Treatment Device Revenue
- 3.4 Global Uterine Fibroid Treatment Device Market Concentration Ratio
- 3.4.1 Global Uterine Fibroid Treatment Device Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroid Treatment Device Revenue in 2019
- 3.5 Key Players Uterine Fibroid Treatment Device Area Served
- 3.6 Key Players Uterine Fibroid Treatment Device Product Solution and Service
- 3.7 Date of Enter into Uterine Fibroid Treatment Device Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Uterine Fibroid Treatment Device Breakdown Data by Type (2015-2026)
- 4.1 Global Uterine Fibroid Treatment Device Historic Market Size by Type (2015-2020)
- 4.2 Global Uterine Fibroid Treatment Device Forecasted Market Size by Type (2021-2026)
5 Uterine Fibroid Treatment Device Breakdown Data by Application (2015-2026)
- 5.1 Global Uterine Fibroid Treatment Device Historic Market Size by Application (2015-2020)
- 5.2 Global Uterine Fibroid Treatment Device Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Uterine Fibroid Treatment Device Market Size (2015-2026)
- 6.2 North America Uterine Fibroid Treatment Device Market Size by Type (2015-2020)
- 6.3 North America Uterine Fibroid Treatment Device Market Size by Application (2015-2020)
- 6.4 North America Uterine Fibroid Treatment Device Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Uterine Fibroid Treatment Device Market Size (2015-2026)
- 7.2 Europe Uterine Fibroid Treatment Device Market Size by Type (2015-2020)
- 7.3 Europe Uterine Fibroid Treatment Device Market Size by Application (2015-2020)
- 7.4 Europe Uterine Fibroid Treatment Device Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Uterine Fibroid Treatment Device Market Size (2015-2026)
- 8.2 China Uterine Fibroid Treatment Device Market Size by Type (2015-2020)
- 8.3 China Uterine Fibroid Treatment Device Market Size by Application (2015-2020)
- 8.4 China Uterine Fibroid Treatment Device Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Uterine Fibroid Treatment Device Market Size (2015-2026)
- 9.2 Japan Uterine Fibroid Treatment Device Market Size by Type (2015-2020)
- 9.3 Japan Uterine Fibroid Treatment Device Market Size by Application (2015-2020)
- 9.4 Japan Uterine Fibroid Treatment Device Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Uterine Fibroid Treatment Device Market Size (2015-2026)
- 10.2 Southeast Asia Uterine Fibroid Treatment Device Market Size by Type (2015-2020)
- 10.3 Southeast Asia Uterine Fibroid Treatment Device Market Size by Application (2015-2020)
- 10.4 Southeast Asia Uterine Fibroid Treatment Device Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 Medtronic
- 11.1.1 Medtronic Company Details
- 11.1.2 Medtronic Business Overview
- 11.1.3 Medtronic Uterine Fibroid Treatment Device Introduction
- 11.1.4 Medtronic Revenue in Uterine Fibroid Treatment Device Business (2015-2020))
- 11.1.5 Medtronic Recent Development
- 11.2 Stryker Corporation
- 11.2.1 Stryker Corporation Company Details
- 11.2.2 Stryker Corporation Business Overview
- 11.2.3 Stryker Corporation Uterine Fibroid Treatment Device Introduction
- 11.2.4 Stryker Corporation Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.2.5 Stryker Corporation Recent Development
- 11.3 Boston Scientific Corporation
- 11.3.1 Boston Scientific Corporation Company Details
- 11.3.2 Boston Scientific Corporation Business Overview
- 11.3.3 Boston Scientific Corporation Uterine Fibroid Treatment Device Introduction
- 11.3.4 Boston Scientific Corporation Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.3.5 Boston Scientific Corporation Recent Development
- 11.4 INSIGHTEC
- 11.4.1 INSIGHTEC Company Details
- 11.4.2 INSIGHTEC Business Overview
- 11.4.3 INSIGHTEC Uterine Fibroid Treatment Device Introduction
- 11.4.4 INSIGHTEC Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.4.5 INSIGHTEC Recent Development
- 11.5 CooperSurgical Inc.
- 11.5.1 CooperSurgical Inc. Company Details
- 11.5.2 CooperSurgical Inc. Business Overview
- 11.5.3 CooperSurgical Inc. Uterine Fibroid Treatment Device Introduction
- 11.5.4 CooperSurgical Inc. Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.5.5 CooperSurgical Inc. Recent Development
- 11.6 Hologic, Inc.
- 11.6.1 Hologic, Inc. Company Details
- 11.6.2 Hologic, Inc. Business Overview
- 11.6.3 Hologic, Inc. Uterine Fibroid Treatment Device Introduction
- 11.6.4 Hologic, Inc. Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.6.5 Hologic, Inc. Recent Development
- 11.7 Lumenis
- 11.7.1 Lumenis Company Details
- 11.7.2 Lumenis Business Overview
- 11.7.3 Lumenis Uterine Fibroid Treatment Device Introduction
- 11.7.4 Lumenis Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.7.5 Lumenis Recent Development
- 11.8 Gynesonics
- 11.8.1 Gynesonics Company Details
- 11.8.2 Gynesonics Business Overview
- 11.8.3 Gynesonics Uterine Fibroid Treatment Device Introduction
- 11.8.4 Gynesonics Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.8.5 Gynesonics Recent Development
- 11.9 Chongqing Haifu Medical Technology
- 11.9.1 Chongqing Haifu Medical Technology Company Details
- 11.9.2 Chongqing Haifu Medical Technology Business Overview
- 11.9.3 Chongqing Haifu Medical Technology Uterine Fibroid Treatment Device Introduction
- 11.9.4 Chongqing Haifu Medical Technology Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.9.5 Chongqing Haifu Medical Technology Recent Development
- 11.10 Shenzhen PRO HITU Medical
- 11.10.1 Shenzhen PRO HITU Medical Company Details
- 11.10.2 Shenzhen PRO HITU Medical Business Overview
- 11.10.3 Shenzhen PRO HITU Medical Uterine Fibroid Treatment Device Introduction
- 11.10.4 Shenzhen PRO HITU Medical Revenue in Uterine Fibroid Treatment Device Business (2015-2020)
- 11.10.5 Shenzhen PRO HITU Medical Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Uterine Fibroid Treatment Device market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Fibroid Treatment Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Surgical Techniques
Laparoscopic Techniques
Ablation Techniques
Embolization Technique
Market segment by Application, split into
Invasive Treatment
Minimally Invasive Treatment
Non-invasive Treatment
Based on regional and country-level analysis, the Uterine Fibroid Treatment Device market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Uterine Fibroid Treatment Device market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Medtronic
Stryker Corporation
Boston Scientific Corporation
INSIGHTEC
CooperSurgical Inc.
Hologic, Inc.
Lumenis
Gynesonics
Chongqing Haifu Medical Technology